Loading...
PhD Milica Perišić Nanut

PhD Milica Perišić Nanut
no.: 36596 source: ARIS

researcher – active in research organisation
Research activity

Code Science Field Subfield
4.00.00  Biotechnical sciences     
4.06.00  Biotechnical sciences  Biotechnology   
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Points
594.37
A''
28.23
A'
279.98
A1/2
304.98
CI10
787
CImax
94
h10
16
A1
1.99
A3
0
Data for the last 5 years (citations for the last 10 years) on December 8, 2025; Data for score A3 calculation refer to period 2020-2024
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 55  1,038  823  14.96 
Scopus 55  1,135  895  16.27 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 PhD Emanuela Senjor   Bologna doctoral studies  10/1/2019 - 9/30/2022  51713 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (100%, RD:100%)  Jožef Stefan Institute  Odsek za biotehnologijo (Slovene) 
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J3-60067  Cathepsin Targeted Immunotherapy for Pancreatic Cancer Treatment -CATIMMPACT   1/1/2025 - 12/31/2027  PhD Milica Perišić Nanut   2,328 
2. J7-60132  Precision medicine in IgA vasculitis   1/1/2025 - 12/31/2027  PhD Alojzija Hočevar   4,813 
3. J2-50064  Electroporation as a potentiator of antimicrobial efficacy   10/1/2023 - 9/30/2026  PhD Tadej Kotnik   3,738 
4. J4-4548  Microplastics as a vector of pathogens contamination, infection and resistance: a case of Campylobacter in poultry production and processing   11/1/2022 - 9/30/2026  PhD Anja Klančnik   2,215 
5. BI-RS/23-25-044  Evaluation of the effects of cystatin F inhibition in experimental autoimmune encephalomyelitis: Potential therapeutic approach for multiple sclerosis (TARGET-CYSF-MS)   7/1/2023 - 12/31/2025  PhD Milica Perišić Nanut   166 
6. J3-3079  Bactericidal nanoblades: a proof-of-concept approach for bimodal chemo-mechanical eradication of persistent biofilms   12/1/2021 - 11/30/2025  PhD Stane Pajk   2,925 
7. J4-4555  Exploring the biofilm phenotype and surfactome of Listeria monocytogenes to predict its persistence and pathogenicity potential using machine learning   10/1/2022 - 9/30/2025  PhD Jerica Sabotič   2,618 
8. J3-4531  On-demand Contact Based Antimicrobial Surfaces: Human and Environmental Safe Infection Control Strategy   10/1/2022 - 9/30/2025  PhD Marija Vukomanović   1,592 
9. J7-4420  Selective mechanical removal of bacterial biofilms by conjugated magnetic nanoparticles   10/1/2022 - 9/30/2025  PhD Aleš Berlec   4,373 
10. J3-4503  Translational irregularities underlying C9orf72-associated amyotrophic lateral sclerosis and frontotemporal dementia   10/1/2022 - 9/30/2025  PhD Boris Rogelj   1,892 
11. J3-3071  Cathepsins B and X in breast cancer stem cells – molecular targets and relevance for antitumor therapy   10/1/2021 - 3/31/2025  PhD Ana Mitrović   2,885 
12. J4-3088  Intra-biofilm dynamics of Campylobacter with other bacteria: effects on biofilm formation and composition with a view to the design of innovative control strategies   10/1/2021 - 9/30/2024  PhD Anja Klančnik   4,545 
13. BI-US/22-24-155  Enhancement of NK cell cytotoxicity by cystatin F modulation   7/1/2022 - 6/30/2024  PhD Milica Perišić Nanut   166 
14. J4-2543  FunContrAPest: Novel Fungal Proteins as Biopesticides for Control of Challenging Invasive Alien Agricultural Pests   11/1/2020 - 10/31/2023  PhD Jerica Sabotič   2,561 
15. J3-2516  Cystatin f as a mediator of immunosuppression in glioblastoma microenvironment   9/1/2020 - 8/31/2023  PhD Milica Perišić Nanut   2,949 
16. J4-1776  Improvement of immunotherapeutic potential of NK cells through modulation of cystatin F   7/1/2019 - 6/30/2022  PhD Janko Kos   3,365 
17. J4-1771  NEW ANTIMICROBIAL STRATEGIES IN PREVENTION OF BIOFILM FORMATION BY USING LECTINS THAT INHIBIT BACTERIAL ADHESION   7/1/2019 - 6/30/2022  PhD Jerica Sabotič   2,457 
18. J4-9299  Targeting Campylobacter adhesion in the fight against antimicrobial resistance   7/1/2018 - 6/30/2022  PhD Anja Klančnik   4,017 
19. J3-9267  Inhibition of cathepsin X activity as a novel strategy for the treatment of Parkinson's disease   7/1/2018 - 6/30/2021  PhD Anja Pišlar   3,044 
20. J4-8227  Preprečevanje rezistence tumorskih celic na antiproteazno terapijo z inhibitorji katepsina X. (Slovene)   5/1/2017 - 4/30/2020  PhD Janko Kos   5,177 
21. J4-6811  Vloga inhibitorjev cisteinskih proteaz v citotoksičnem delovanju naravnih celic ubijalk na tumorske celice (Slovene)   7/1/2014 - 6/30/2017  PhD Janko Kos   2,837 
22. J4-5529  Nitroksolin in njegovi derivati kot nova protitumorska zdravila (Slovene)   8/1/2013 - 7/31/2016  PhD Janko Kos   6,651 
23. J4-4123  Inhibitorji cisteinskih karboksipeptidaz kot regulatorji avtoimunskih in nevrodegenerativnih procesov (Slovene)   7/1/2011 - 6/30/2014  PhD Janko Kos   6,994 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head No. of publications
1. P4-0127  Pharmaceutical biotechnology: Science for health   1/1/2019 - 12/31/2027 PhD Anja Pišlar   5,816 
2. P4-0127  Pharmaceutical biotechnology: Science for Health   1/1/2015 - 12/31/2018 PhD Janko Kos   5,473 
3. P4-0127  Pharmaceutical biotechnology: Knowledge for Health   1/1/2009 - 12/31/2014 PhD Janko Kos   5,995 
We were not given permission by the researcher to publish data.
Views history
Favourite